A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Oct 9, 2026 - P1 | N=138 | Completed | Sponsor: Toray Industries, Inc | Active, not recruiting ➔ Completed
Platinum resistant • Trial completion • Biliary Cancer • Bladder Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Epithelial Ovarian Cancer • Fallopian Tube Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Genito-urinary Cancer • Melanoma • Oncology • Ovarian Cancer • Peritoneal Cancer • Renal Cell Carcinoma • Solid Tumor • BRCA1 • BRCA2
|